Global Cancer Burden 2022: Impact of Modifiable Risk Factors and Prevention Strategies
Recent global analyses reveal that cancer incidence and mortality continue to rise across 185 countries, yet a growing share of deaths is being averted through prevention, early detection, and treatment advances.
Global Cancer Landscape
The GLOBOCAN 2022 estimates compiled by Bray et al. (2024) provide the most comprehensive snapshot of 36 cancer types worldwide, documenting rising case numbers and mortality trends that underscore the urgency of public‑health action.
The Role of Modifiable Risk Factors
Stein & Colditz (2004) identified tobacco use, unhealthy diet, excess body weight, physical inactivity, and infections as key modifiable drivers of cancer. A systematic review by Tran et al. (2022) quantified the global burden of cancers attributable to these risk factors between 2010 and 2019, confirming that lifestyle and environmental exposures account for a substantial proportion of cases. Whiteman & Wilson (2016) further emphasized that many cancers could be prevented by addressing these factors.
Successes in Prevention, Screening, and Treatment
Goddard et al. (2025) estimated that more than 2 million cancer deaths were averted from 1975 to 2020 thanks to coordinated prevention, screening, and therapeutic programmes. Arnold et al. (2019) reported continued improvements in survival and reduced mortality in seven high‑income nations, while Shelton et al. (2024) documented a 25‑year decline in cancer incidence and mortality among UK adults aged 35‑69, reflecting the impact of sustained public‑health efforts.
Infections and Vaccination
Infection‑related cancers remain a major concern. De Martel et al. (2020) highlighted that hepatitis B and C, human papillomavirus (HPV), and Helicobacter pylori together account for a sizable share of global cancer cases. Mass eradication of H. pylori on Taiwan’s Matsu Islands (Chiang et al., 2021) demonstrated a long‑term reduction in gastric cancer incidence and mortality. HPV vaccination has been shown to markedly lower the risk of invasive cervical cancer (Lei et al., 2020), and hepatitis B vaccination programmes in Egypt have proven effective (Salama et al., 2015).
Lifestyle Factors – Tobacco, Alcohol, Obesity, Physical Activity
WHO’s 2023 tobacco report confirms that smoking remains the leading preventable cause of cancer, although recent WHO and GBD data (GBD 2019 Tobacco Collaborators, 2021) show declining prevalence in many regions. Alcohol exposure, modelled by Manthey et al. (2019), continues to contribute to cancer risk, with Bagnardi et al. (2015) documenting dose‑response relationships for multiple cancer sites. Rising body‑mass index trends reported by the NCD‑Risk‑Factor Collaboration (2024) link obesity to increased incidence of several cancers, while insufficient physical activity remains prevalent (WHO, 2017).
Looking Ahead
Forecasts from the Global Burden of Disease 2023 study (Lancet 406, 2025) suggest that, without accelerated action on modifiable risks, cancer incidence could continue to rise toward 2050. Strengthening vaccination programmes, expanding screening, and implementing gender‑responsive tobacco policies (WHO Framework Convention, 2018) could further reduce the preventable cancer burden. Emerging models for estimating alcohol consumption (Kehoe et al., 2012) and refined physical‑activity monitoring (Shupler et al., 2018) may improve future risk assessments.
Frequently Asked Questions
What proportion of cancers is linked to modifiable risk factors?
Systematic reviews (Stein & Colditz, 2004; Whiteman & Wilson, 2016) and the Global Burden of Disease analysis (Tran et al., 2022) indicate that a large share of cancers worldwide can be attributed to lifestyle, environmental, and infectious exposures that are preventable.
Which infections contribute most to the global cancer burden?
Key infection‑related cancers arise from hepatitis B and C viruses, HPV, and Helicobacter pylori, as detailed by de Martel et al. (2020) and corroborated by specific burden studies on gastric (Plummer et al., 2015) and cervical cancers (Lei et al., 2020).
How have prevention and treatment advances affected cancer deaths?
Goddard et al. (2025) estimate that over two million deaths were averted between 1975 and 2020 due to combined prevention, screening, and treatment efforts. Improvements in survival and reduced mortality have also been documented in high‑income countries (Arnold et al., 2019) and the United Kingdom (Shelton et al., 2024).
What steps could your community take today to lower its cancer risk?